Blog
RSS FeedPosted by Michael Wonder on 20 Aug 2018
Evolus granted approval of DWP-450 by Health Canada
17 August 2018 - Evolus today announced that Health Canada has granted approval of DWP-450 (prabotulinumtoxinA) for the temporary improvement ...
Posted by Michael Wonder on 17 Aug 2018
Health Canada proposes ‘pause the clock’ mechanism for pre-market submissions
15 August 2018 - Health Canada recently released for consultation a plan to establish a mechanism that allows for the ...
Posted by Michael Wonder on 15 Aug 2018
Galderma Canada announces new indication for Dysport Aesthetic
14 August 2018 - Galderma Canada is pleased to announce that Health Canada has approved Dysport Aesthetic (abobotulinumtoxinA) for the temporary ...
Posted by Michael Wonder on 08 Aug 2018
Health Canada approves Hemlibra for haemophilia A patients with inhibitors
7 August 2018 - Hemlibra is the first new treatment in almost 20 years for this most severe form of ...
Posted by Michael Wonder on 06 Aug 2018
EpiPen shortage is critical – and not easy to fix
2 August 2018 - An estimated 2.6 million Canadians suffer from serious allergies and about 630,000 of them carry an ...
Posted by Michael Wonder on 02 Aug 2018
Aimovig (erenumab), a novel treatment developed specifically for migraine prevention receives Health Canada approval
2 August 2018 - Aimovig consistently shown to reduce monthly migraine days, with many patients achieving a 50% reduction or more. ...
Posted by Michael Wonder on 02 Aug 2018
Amid EpiPen shortage, a Canadian-based company has approval for an alternative
1 August 2018 - Bausch Health says it is 'actively seeking' to bring anaphylaxis injector to Canadian patients. ...
Posted by Michael Wonder on 31 Jul 2018
New treatment option for Canadians with metastatic lung cancer
30 July 2018 - Takeda Canada has received Notice of Compliance with conditions approval from Health Canada for Alunbrig (brigatinib) indicated ...
Posted by Michael Wonder on 17 Jul 2018
OPKO partner Vifor Fresenius receives marketing approval for Rayaldee in Canada
16 July 2018 - OPKO Health announced today that the Company’s partner Vifor Fresenius Medical Care Renal Pharma has received ...
Posted by Michael Wonder on 13 Jul 2018
Health Canada ordered to release confidential drug company data on HPV vaccines
13 July 2018 - Federal government insisted drug companies' clinical trial data is 'confidential business information'. ...
Posted by Michael Wonder on 13 Jul 2018
Gilead receives approval in Canada for Biktarvy (bictegravir, emtricitabine, tenofovir alafenamide) for the treatment of HIV-1 infection
12 July 2018 - Gilead Sciences Canada today announced that Health Canada has granted a notice of compliance for Biktarvy (bictegravir ...
Posted by Michael Wonder on 13 Jul 2018
Health Canada approves Tagrisso (osimertinib) as first-line treatment for EGFR-mutated non-small cell lung cancer
12 July 2018 - Pivotal FLAURA study demonstrated 18.9 months median progression-free survival for patients receiving Tagrisso versus 10.2 months compared ...
Posted by Michael Wonder on 11 Jul 2018
Ottawa heightens scrutiny on opioid manufacturers’ marketing
11 July 2018 - The federal government is stepping up its regulatory scrutiny of opioid manufacturers and signalling that it ...
Posted by Michael Wonder on 10 Jul 2018
Health Canada approves Gazyva for previously untreated advanced follicular lymphoma
9 July 2018 - Gazyva is the first anti-CD20 treatment in 15 years for the most common subtype of indolent lymphoma. ...
Posted by Michael Wonder on 09 Jul 2018
Only immuno-oncology combination therapy approved by Health Canada as first-line treatment for advanced or metastatic renal cell carcinoma
9 July 2018 - Opdivo (nivolumab) and Yervoy (ipilimumab) combination is the first and only treatment to show significantly superior ...